During the past decade, Dalhousie MS Research Unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dalhousie MS Research Unit" #1 sponsor was "Biogen" with 2 trials, followed by "Dr. Luanne Metz" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "University of British Columbia" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dalhousie MS Research Unit" #1 collaborator was "British Columbia Clinical Genomics Network" with 1 trials as a collaborator, "Canada Foundation for Innovation" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator, "Genome Canada" with 1 trials as a collaborator and "Multiple Sclerosis Society of Canada" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Dalhousie MS Research Unit" are "Multiple Sclerosis" (2 trials), "Clinically Isolated Syndromes" (1 trials), "Early Single Relapse of Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Primary Progressive" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Dalhousie MS Research Unit" in a lesser frequency.

Most popular intervention types in "Dalhousie MS Research Unit" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (2 trials), "Placebo" (2 trials) and "Minocycline" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dalhousie MS Research Unit" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Dalhousie MS Research Unit". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dalhousie MS Research Unit, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dalhousie MS Research Unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".